Clinicians’ Experience with ADHD Treatments
Panelists discuss how viloxazine fits into both pediatric and adult attention-deficity/hyperactivity disorder (ADHD) treatment plans, especially as a nonstimulant option for patients with complex cases or concerns about stimulant adverse effects, while emphasizing flexible dosing and caregiver involvement.
Watch
Viloxazine for ADHD in Children and Adolescents
Panelists discuss how recent clinical studies on viloxazine in children and adolescents with ADHD demonstrated early symptom improvement, dose-dependent efficacy, and tolerability, with the most benefit seen at 400 mg in those aged 11 and under.
Watch
Role of Pitolisant in Management of Narcolepsy
July 7th 2025Panelists discuss the clinical and practical advantages of pitolisant for patients with frequent cataplexy and concerns about controlled substances, highlighting its dual efficacy, favorable safety profile, and flexible dosing as key features that support a patient-centered, stigma-conscious approach to narcolepsy care.
Watch
Patient Education and Shared Decision-Making in Narcolepsy
July 7th 2025Panelists discuss the importance of shared decision-making in narcolepsy care, emphasizing structured conversations that explore patient goals, treatment preferences, and concerns—while navigating practical barriers like insurance—so that therapy selection is personalized and collaborative, often requiring a multimodal approach for optimal outcomes.
Watch
A Case of a 32-Year-Old Male With Type 1 Narcolepsy
June 30th 2025Panelists discuss the critical importance of early diagnosis and personalized treatment in narcolepsy, using a case study to illustrate how tailored therapy—considering patient preferences, comorbidities, and lifestyle factors—can improve engagement, safety, and long-term outcomes.
Watch
Current State of Treatment Landscape and Unmet Needs in Narcolepsy Management
June 30th 2025Panelists discuss the evolving treatment landscape for narcolepsy, highlighting the growing availability of personalized therapies, persistent challenges with diagnosis and access, and the importance of clinician advocacy and education to ensure timely, individualized care for patients.
Watch
50 Years Later: Advice for New Psychiatrists
June 25th 2025July 1 marks 50 years in psychiatry for H. Steven Moffic, MD! In celebration, he shares essential advice for aspiring psychiatrists, emphasizing ethical decision-making, flexibility, and the importance of passion in mental health careers.
Watch
Role of Pediatricians in Diagnosing ADHD
Panelists discuss the critical role of pediatricians in attention-deficity/hyperactivity disorder (ADHD) diagnosis and treatment challenges.
Watch
Impact of ADHD on Patient’s Quality of Life
Panelists discuss how an attention-deficity/hyperactivity disorder (ADHD) diagnosis impacts families through stress and challenges but can also provide relief and understanding. They address quality-of-life effects including academic performance, family functioning, driving safety, and the need for structure and routine management.
Watch
Panelists discuss how diagnostic challenges include ensuring symptoms are developmentally appropriate, distinguishing attention-deficity/hyperactivity disorder (ADHD) from other conditions such as depression and anxiety and using tools such as the NICHQ Vanderbilt Assessment Scales and Connors Comprehensive Behavior Rating Scale to assess symptoms across multiple settings.
Watch